Human disease
rheumatoid arthritis
Mondo defines it as: “A chronic, systemic autoimmune disorder characterized by inflammation in the synovial membranes and articular surfaces. It manifests primarily as a symmetric, erosive polyarthritis that spares the axial skeleton and is typically associated with the presence in the serum of rheumatoid factor.”
1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.
Animal diseases
By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.
| OMIA group | Name | Found by | Species | The chain reached | Score |
|---|---|---|---|---|---|
| 67 | Arthritis, rheumatoid | OMIA's OMIM numbers | 1 | Human disease |
34.0
|
Human genes
Each human gene of these disease groups that Open Targets links to this disease.
Open Targets links none of these groups' human genes to this disease.
Drugs tested for this disease
Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.
| Drug | Acts on | Latest stage for this disease |
|---|---|---|
| Abatacept | None of these genes | Approved |
| Aceclofenac | None of these genes | Approved |
| Adalimumab | None of these genes | Approved |
| Alclofenac | None of these genes | Approved |
| Anakinra | None of these genes | Approved |
| Auranofin | None of these genes | Approved |
| Azathioprine | None of these genes | Approved |
| Baricitinib | None of these genes | Approved |
| Canakinumab | None of these genes | Approved |
| Celecoxib | None of these genes | Approved |
| Certolizumab | None of these genes | Approved |
| Certolizumab Pegol | None of these genes | Approved |
| Cortisone Acetate | None of these genes | Approved |
| Cyclosporine | None of these genes | Approved |
| Dexamethasone | None of these genes | Approved |
| Dexamethasone Phosphoric Acid | None of these genes | Approved |
| Diclofenac | None of these genes | Approved |
| Diflunisal | None of these genes | Approved |
| Dimethyl Sulfoxide | None of these genes | Approved |
| Esomeprazole | None of these genes | Approved |
| Etanercept | None of these genes | Approved |
| Etodolac | None of these genes | Approved |
| Etofenamate | None of these genes | Approved |
| Etoricoxib | None of these genes | Approved |
| Famotidine | None of these genes | Approved |
| Fenoprofen | None of these genes | Approved |
| Filgotinib | None of these genes | Approved |
| Flurbiprofen | None of these genes | Approved |
| Gold Sodium Thiomalate | None of these genes | Approved |
| Golimumab | None of these genes | Approved |
| Hydrocortisone | None of these genes | Approved |
| Hydroxychloroquine | None of these genes | Approved |
| Ibuprofen | None of these genes | Approved |
| Iguratimod | None of these genes | Approved |
| Indomethacin | None of these genes | Approved |
| Infliximab | None of these genes | Approved |
| Inosine | None of these genes | Approved |
| Isopropyl Alcohol | None of these genes | Approved |
| Ketoprofen | None of these genes | Approved |
| Leflunomide | None of these genes | Approved |
| Meclofenamic Acid | None of these genes | Approved |
| Meloxicam | None of these genes | Approved |
| Methotrexate | None of these genes | Approved |
| Methylprednisolone | None of these genes | Approved |
| Methylprednisolone Acetate | None of these genes | Approved |
| Methylprednisolone Hemisuccinate | None of these genes | Approved |
| Misoprostol | None of these genes | Approved |
| Nabumetone | None of these genes | Approved |
| Naproxen | None of these genes | Approved |
| Niflumic Acid | None of these genes | Approved |
| Omeprazole | None of these genes | Approved |
| Oxaprozin | None of these genes | Approved |
| Ozoralizumab | None of these genes | Approved |
| Peficitinib | None of these genes | Approved |
| Penicillamine | None of these genes | Approved |
| Piroxicam | None of these genes | Approved |
| Prasterone | None of these genes | Approved |
| Prednisolone | None of these genes | Approved |
| Prednisone | None of these genes | Approved |
| Rituximab | None of these genes | Approved |
| Salsalate | None of these genes | Approved |
| Sarilumab | None of these genes | Approved |
| Sulfasalazine | None of these genes | Approved |
| Sulindac | None of these genes | Approved |
| Tenoxicam | None of these genes | Approved |
| Tocilizumab | None of these genes | Approved |
| Tofacitinib | None of these genes | Approved |
| Tolmetin | None of these genes | Approved |
| Triamcinolone Acetonide | None of these genes | Approved |
| Trientine | None of these genes | Approved |
| Upadacitinib | None of these genes | Approved |
| Valdecoxib | None of these genes | Approved |
| Amiprilose | None of these genes | Awaiting approval |
| Bucillamine | None of these genes | Phase 3 |
| Chloroquine | None of these genes | Phase 3 |
| Cilengitide | None of these genes | Phase 3 |
| Cilostazol | None of these genes | Phase 3 |
| Cipemastat | None of these genes | Phase 3 |
| Corticotropin | None of these genes | Phase 3 |
| Diosmin | None of these genes | Phase 3 |
| Ergocalciferol | None of these genes | Phase 3 |
| Escitalopram | None of these genes | Phase 3 |
| Eszopiclone | None of these genes | Phase 3 |
| Fish Oil | None of these genes | Phase 3 |
| Folic Acid | None of these genes | Phase 3 |
| Fostamatinib | None of these genes | Phase 3 |
| Gamolenic Acid | None of these genes | Phase 3 |
| Glucosamine | None of these genes | Phase 3 |
| Gw-406381 | None of these genes | Phase 3 |
| Hesperidin | None of these genes | Phase 3 |
| Icosapent | None of these genes | Phase 3 |
| Ivarmacitinib | None of these genes | Phase 3 |
| Levilimab | None of these genes | Phase 3 |
| Levocarnitine | None of these genes | Phase 3 |
| Losartan | None of these genes | Phase 3 |
| Lumiracoxib | None of these genes | Phase 3 |
| Minocycline | None of these genes | Phase 3 |
| Mizoribine | None of these genes | Phase 3 |
| Montelukast | None of these genes | Phase 3 |
| Nerelimomab | None of these genes | Phase 3 |
| Nicorandil | None of these genes | Phase 3 |
| Nitazoxanide | None of these genes | Phase 3 |
| Ocrelizumab | None of these genes | Phase 3 |
| Ofatumumab | None of these genes | Phase 3 |
| Olokizumab | None of these genes | Phase 3 |
| Omega-3 Fatty Acids | None of these genes | Phase 3 |
| Otilimab | None of these genes | Phase 3 |
| Paroxetine | None of these genes | Phase 3 |
| Pelubiprofen | None of these genes | Phase 3 |
| Piclidenoson | None of these genes | Phase 3 |
| Resiniferatoxin | None of these genes | Phase 3 |
| Resveratrol | None of these genes | Phase 3 |
| Rupatadine | None of these genes | Phase 3 |
| Satralizumab | None of these genes | Phase 3 |
| Secukinumab | None of these genes | Phase 3 |
| Sirukumab | None of these genes | Phase 3 |
| Sivelestat | None of these genes | Phase 3 |
| Spermidine | None of these genes | Phase 3 |
| Spironolactone | None of these genes | Phase 3 |
| Tabalumab | None of these genes | Phase 3 |
| Tacrolimus Anhydrous | None of these genes | Phase 3 |
| Telitacicept | None of these genes | Phase 3 |
| Tenidap | None of these genes | Phase 3 |
| Teriflunomide | None of these genes | Phase 3 |
| Triamcinolone Hexacetonide | None of these genes | Phase 3 |
| Ustekinumab | None of these genes | Phase 3 |
| Vanadate | None of these genes | Phase 3 |
| Varespladib Methyl | None of these genes | Phase 3 |
| Zemprocitinib | None of these genes | Phase 3 |
| Chromium | None of these genes | Phase 2/3 |
| Decernotinib | None of these genes | Phase 2/3 |
| Masitinib | None of these genes | Phase 2/3 |
| Ramipril | None of these genes | Phase 2/3 |
| Ubidecarenone | None of these genes | Phase 2/3 |
| Vitamin E | None of these genes | Phase 2/3 |
| Zanolimumab | None of these genes | Phase 2/3 |
| 2-(Aminomethyl)Phenol | None of these genes | Phase 2 |
| Abbv-3373 | None of these genes | Phase 2 |
| Acalabrutinib | None of these genes | Phase 2 |
| Adalimumab Fosimdesonide | None of these genes | Phase 2 |
| Adl-5859 | None of these genes | Phase 2 |
| Afimkibart | None of these genes | Phase 2 |
| Ak-106 | None of these genes | Phase 2 |
| Aldesleukin | None of these genes | Phase 2 |
| Alendronic Acid | None of these genes | Phase 2 |
| Amelubant | None of these genes | Phase 2 |
| Amg-108 | None of these genes | Phase 2 |
| Aminocaproic Acid | None of these genes | Phase 2 |
| Aminopterin | None of these genes | Phase 2 |
| Andecaliximab | None of these genes | Phase 2 |
| Anifrolumab | None of these genes | Phase 2 |
| Apilimod | None of these genes | Phase 2 |
| Apilimod | None of these genes | Phase 2 |
| Apratastat | None of these genes | Phase 2 |
| Apremilast | None of these genes | Phase 2 |
| Apricoxib | None of these genes | Phase 2 |
| Arginine | None of these genes | Phase 2 |
| Atacicept | None of these genes | Phase 2 |
| Atorvastatin | None of these genes | Phase 2 |
| Azd5672 | None of these genes | Phase 2 |
| Azd9056 | None of these genes | Phase 2 |
| Baminercept | None of these genes | Phase 2 |
| Bazlitoran | None of these genes | Phase 2 |
| Belimumab | None of these genes | Phase 2 |
| Belumosudil | None of these genes | Phase 2 |
| Betamethasone | None of these genes | Phase 2 |
| Betamethasone Phosphoric Acid | None of these genes | Phase 2 |
| Biib-023 | None of these genes | Phase 2 |
| Bimekizumab | None of these genes | Phase 2 |
| Binimetinib | None of these genes | Phase 2 |
| Blinatumomab | None of these genes | Phase 2 |
| Bms-582949 | None of these genes | Phase 2 |
| Bms-817399 | None of these genes | Phase 2 |
| Bms-986142 | None of these genes | Phase 2 |
| Bortezomib | None of these genes | Phase 2 |
| Branebrutinib | None of these genes | Phase 2 |
| Briobacept | None of these genes | Phase 2 |
| Brodalumab | None of these genes | Phase 2 |
| Burfiralimab | None of these genes | Phase 2 |
| Calcium | None of these genes | Phase 2 |
| Camobucol | None of these genes | Phase 2 |
| Cannabidiol | None of these genes | Phase 2 |
| Carnitine | None of these genes | Phase 2 |
| Ccx354 | None of these genes | Phase 2 |
| Ce-224535 | None of these genes | Phase 2 |
| Cenplacel-L | None of these genes | Phase 2 |
| Cetrorelix | None of these genes | Phase 2 |
| Ch-1504 | None of these genes | Phase 2 |
| Ch-1504 L-Isomer | None of these genes | Phase 2 |
| Cholecalciferol | None of these genes | Phase 2 |
| Clazakizumab | None of these genes | Phase 2 |
| Clenoliximab | None of these genes | Phase 2 |
| Colchicine | None of these genes | Phase 2 |
| Cp-195543 | None of these genes | Phase 2 |
| Cyclophosphamide Anhydrous | None of these genes | Phase 2 |
| Dazodalibep | None of these genes | Phase 2 |
| Dazukibart | None of these genes | Phase 2 |
| Denosumab | None of these genes | Phase 2 |
| Desloratadine | None of these genes | Phase 2 |
| Diacerein | None of these genes | Phase 2 |
| Digoxin | None of these genes | Phase 2 |
| Dilmapimod | None of these genes | Phase 2 |
| Dimethyl Fumarate | None of these genes | Phase 2 |
| Dipyridamole | None of these genes | Phase 2 |
| Disulfiram | None of these genes | Phase 2 |
| Doramapimod | None of these genes | Phase 2 |
| Dronabinol | None of these genes | Phase 2 |
| Duvelisib | None of these genes | Phase 2 |
| Edecesertib | None of these genes | Phase 2 |
| Edicotinib | None of these genes | Phase 2 |
| Efalizumab | None of these genes | Phase 2 |
| Elasomeran | None of these genes | Phase 2 |
| Eldelumab | None of these genes | Phase 2 |
| Elsubrutinib | None of these genes | Phase 2 |
| Emvododstat | None of these genes | Phase 2 |
| Epoetin Alfa | None of these genes | Phase 2 |
| Etaracizumab | None of these genes | Phase 2 |
| Evobrutinib | None of these genes | Phase 2 |
| Fenebrutinib | None of these genes | Phase 2 |
| Fezakinumab | None of these genes | Phase 2 |
| Fletikumab | None of these genes | Phase 2 |
| Fludarabine | None of these genes | Phase 2 |
| Fontolizumab | None of these genes | Phase 2 |
| Fosbretabulin | None of these genes | Phase 2 |
| Fosdagrocorat | None of these genes | Phase 2 |
| Gevokizumab | None of these genes | Phase 2 |
| Glpg-0259 | None of these genes | Phase 2 |
| Glpg-3970 | None of these genes | Phase 2 |
| Gsk2982772 | None of these genes | Phase 2 |
| Gsk-3117391 | None of these genes | Phase 2 |
| Guselkumab | None of these genes | Phase 2 |
| Gw-274150 | None of these genes | Phase 2 |
| Ianalumab | None of these genes | Phase 2 |
| Ib-Meca | None of these genes | Phase 2 |
| Imatinib | None of these genes | Phase 2 |
| Incb-047986 | None of these genes | Phase 2 |
| Inebilizumab | None of these genes | Phase 2 |
| Iscalimab | None of these genes | Phase 2 |
| Itacitinib | None of these genes | Phase 2 |
| Itx-5061 Free Base | None of these genes | Phase 2 |
| Ixekizumab | None of these genes | Phase 2 |
| Jnj-39758979 | None of these genes | Phase 2 |
| Keyhole Limpet Hemocyanin | None of these genes | Phase 2 |
| Lanraplenib | None of these genes | Phase 2 |
| Lenabasum | None of these genes | Phase 2 |
| Lenzilumab | None of these genes | Phase 2 |
| Leramistat | None of these genes | Phase 2 |
| Losmapimod | None of these genes | Phase 2 |
| Lovastatin | None of these genes | Phase 2 |
| Loxoprofen | None of these genes | Phase 2 |
| Lutikizumab | None of these genes | Phase 2 |
| Lx-2931 | None of these genes | Phase 2 |
| Maraviroc | None of these genes | Phase 2 |
| Mavrilimumab | None of these genes | Phase 2 |
| Metformin | None of these genes | Phase 2 |
| Methoxsalen | None of these genes | Phase 2 |
| Mizacorat | None of these genes | Phase 2 |
| Mk-0873 | None of these genes | Phase 2 |
| Mk-8457 | None of these genes | Phase 2 |
| Monalizumab | None of these genes | Phase 2 |
| Nabiximols | None of these genes | Phase 2 |
| Namilumab | None of these genes | Phase 2 |
| Natalizumab | None of these genes | Phase 2 |
| Neflamapimod | None of these genes | Phase 2 |
| Niacin | None of these genes | Phase 2 |
| Niacinamide | None of these genes | Phase 2 |
| Nipocalimab | None of these genes | Phase 2 |
| Nnc0114-0006 | None of these genes | Phase 2 |
| Obefazimod | None of these genes | Phase 2 |
| Ocadusertib | None of these genes | Phase 2 |
| Opigolix | None of these genes | Phase 2 |
| Ordesekimab | None of these genes | Phase 2 |
| Paclitaxel | None of these genes | Phase 2 |
| Palmidrol | None of these genes | Phase 2 |
| Pamapimod | None of these genes | Phase 2 |
| Paridiprubart | None of these genes | Phase 2 |
| Pateclizumab | None of these genes | Phase 2 |
| Pd-360324 | None of these genes | Phase 2 |
| Pegsunercept | None of these genes | Phase 2 |
| Pentoxifylline | None of these genes | Phase 2 |
| Peresolimab | None of these genes | Phase 2 |
| Pg-760564 | None of these genes | Phase 2 |
| Ph-797804 | None of these genes | Phase 2 |
| Piclamilast | None of these genes | Phase 2 |
| Pimagedine | None of these genes | Phase 2 |
| Pirfenidone | None of these genes | Phase 2 |
| Placulumab | None of these genes | Phase 2 |
| Poison Oak Extract | None of these genes | Phase 2 |
| Poseltinib | None of these genes | Phase 2 |
| Pralnacasan | None of these genes | Phase 2 |
| Prinaberel | None of these genes | Phase 2 |
| Prt-2607 | None of these genes | Phase 2 |
| Puerarin | None of these genes | Phase 2 |
| Quetmolimab | None of these genes | Phase 2 |
| Ravagalimab | None of these genes | Phase 2 |
| (Rel)-P505-15 | None of these genes | Phase 2 |
| Remtolumab | None of these genes | Phase 2 |
| Resomelagon | None of these genes | Phase 2 |
| Revamilast | None of these genes | Phase 2 |
| Rimacalib | None of these genes | Phase 2 |
| Ritlecitinib | None of these genes | Phase 2 |
| Roflumilast | None of these genes | Phase 2 |
| Rosiglitazone | None of these genes | Phase 2 |
| Rosnilimab | None of these genes | Phase 2 |
| Ruxolitinib | None of these genes | Phase 2 |
| San-300 | None of these genes | Phase 2 |
| Siponimod | None of these genes | Phase 2 |
| Sodium Butyrate | None of these genes | Phase 2 |
| Spebrutinib | None of these genes | Phase 2 |
| Ssr-150106 | None of these genes | Phase 2 |
| Tak-715 | None of these genes | Phase 2 |
| Talmapimod | None of these genes | Phase 2 |
| Taurursodiol | None of these genes | Phase 2 |
| Temsirolimus | None of these genes | Phase 2 |
| Tesnatilimab | None of these genes | Phase 2 |
| Tetanus Toxoid | None of these genes | Phase 2 |
| Tetracycline | None of these genes | Phase 2 |
| Toreforant | None of these genes | Phase 2 |
| Tozinameran | None of these genes | Phase 2 |
| Tranexamic Acid | None of these genes | Phase 2 |
| Tranilast | None of these genes | Phase 2 |
| Tregalizumab | None of these genes | Phase 2 |
| Triamcinolone | None of these genes | Phase 2 |
| Troculeucel | None of these genes | Phase 2 |
| Tru-015 | None of these genes | Phase 2 |
| Tulisokibart | None of these genes | Phase 2 |
| Ucb-1184197 | None of these genes | Phase 2 |
| Ursodiol | None of these genes | Phase 2 |
| Veltuzumab | None of these genes | Phase 2 |
| Venlafaxine | None of these genes | Phase 2 |
| Vidofludimus | None of these genes | Phase 2 |
| Vobarilizumab | None of these genes | Phase 2 |
| Vorbipiprant | None of these genes | Phase 2 |
| Vx-702 | None of these genes | Phase 2 |
| Zimlovisertib | None of these genes | Phase 2 |
| Zunsemetinib | None of these genes | Phase 2 |
| Allopurinol | None of these genes | Phase 1/2 |
| Ask-8007 | None of these genes | Phase 1/2 |
| Belatacept | None of these genes | Phase 1/2 |
| Bevifimod | None of these genes | Phase 1/2 |
| Bezisterim | None of these genes | Phase 1/2 |
| Cannabichromene | None of these genes | Phase 1/2 |
| Efavaleukin Alfa | None of these genes | Phase 1/2 |
| Fexofenadine | None of these genes | Phase 1/2 |
| Morphine | None of these genes | Phase 1/2 |
| Naltrexone | None of these genes | Phase 1/2 |
| Niclosamide | None of these genes | Phase 1/2 |
| Obexelimab | None of these genes | Phase 1/2 |
| Rapcabtagene Autoleucel | None of these genes | Phase 1/2 |
| Rebamipide | None of these genes | Phase 1/2 |
| Tgn-1412 | None of these genes | Phase 1/2 |
| Ab-101 | None of these genes | Phase 1 |
| Abbv-257 | None of these genes | Phase 1 |
| Alemtuzumab | None of these genes | Phase 1 |
| Amp-110 | None of these genes | Phase 1 |
| Antilymphocyte Immunoglobulin (Horse) | None of these genes | Phase 1 |
| Arry-797 | None of these genes | Phase 1 |
| Avdoralimab | None of these genes | Phase 1 |
| Ave-9940 | None of these genes | Phase 1 |
| Azd-6703 | None of these genes | Phase 1 |
| Bms-986104 | None of these genes | Phase 1 |
| Briakinumab | None of these genes | Phase 1 |
| Cabiralizumab | None of these genes | Phase 1 |
| Cizutamig | None of these genes | Phase 1 |
| Curcuminoids | None of these genes | Phase 1 |
| Evt401 | None of these genes | Phase 1 |
| Filgrastim | None of these genes | Phase 1 |
| Genistein | None of these genes | Phase 1 |
| Gimsilumab | None of these genes | Phase 1 |
| Imvotamab | None of these genes | Phase 1 |
| Interleukin 6 | None of these genes | Phase 1 |
| Lenograstim | None of these genes | Phase 1 |
| Mdx-1342 | None of these genes | Phase 1 |
| Mycophenolate Mofetil | None of these genes | Phase 1 |
| Nivolumab | None of these genes | Phase 1 |
| Otelixizumab | None of these genes | Phase 1 |
| Pacibekitug | None of these genes | Phase 1 |
| Pegfilgrastim | None of these genes | Phase 1 |
| Pexidartinib | None of these genes | Phase 1 |
| Plamotamab | None of these genes | Phase 1 |
| Plonmarlimab | None of these genes | Phase 1 |
| Plx-5622 | None of these genes | Phase 1 |
| R-1487 | None of these genes | Phase 1 |
| Resolvin E1 | None of these genes | Phase 1 |
| Roquinimex | None of these genes | Phase 1 |
| Rozibafusp Alfa | None of these genes | Phase 1 |
| Sc-57666 | None of these genes | Phase 1 |
| Simvastatin | None of these genes | Phase 1 |
| Sodium Chloride | None of these genes | Phase 1 |
| Surovatamig | None of these genes | Phase 1 |
| Tadekinig Alfa | None of these genes | Phase 1 |
| Tak-020 | None of these genes | Phase 1 |
| Tasocitinib | None of these genes | Phase 1 |
| Tibulizumab | None of these genes | Phase 1 |
| Timolumab | None of these genes | Phase 1 |
| Tirabrutinib | None of these genes | Phase 1 |
| Vamorolone | None of these genes | Phase 1 |
| Vehicle | None of these genes | Phase 1 |
| Vgx-1027 | None of these genes | Phase 1 |
| Ziltivekimab | None of these genes | Phase 1 |
| Zolacabtagene Autoleucel | None of these genes | Phase 1 |
| Carvedilol | None of these genes | Early phase 1 |
| Curcumin | None of these genes | Early phase 1 |
| Fosmanogepix | None of these genes | Investigational new drug |
| Rosmarinic Acid | None of these genes | Investigational new drug |
| Tenosal | None of these genes | Investigational new drug |
| Romazarit | None of these genes | Preclinical |
| 1 | None of these genes | Unknown |
| 2vl | None of these genes | Unknown |
| Bupivacaine | None of these genes | Unknown |
| Calcitriol | None of these genes | Unknown |
| Citalopram | None of these genes | Unknown |
| Daclatasvir | None of these genes | Unknown |
| Dextromethorphan | None of these genes | Unknown |
| Dextrose | None of these genes | Unknown |
| Diazepam | None of these genes | Unknown |
| Doxycycline Anhydrous | None of these genes | Unknown |
| Entecavir Anhydrous | None of these genes | Unknown |
| Gamcemetinib | None of these genes | Unknown |
| Hyaluronidase | None of these genes | Unknown |
| Influenza A Virus, Split Virion | None of these genes | Unknown |
| Influenza Virus Vaccine | None of these genes | Unknown |
| Insulin Human | None of these genes | Unknown |
| Ledipasvir | None of these genes | Unknown |
| Melatonin | None of these genes | Unknown |
| Ombitasvir | None of these genes | Unknown |
| Paeoniflorin | None of these genes | Unknown |
| Paritaprevir | None of these genes | Unknown |
| Pioglitazone | None of these genes | Unknown |
| Raloxifene | None of these genes | Unknown |
| Ro-319790 | None of these genes | Unknown |
| Simeprevir | None of these genes | Unknown |
| Sofosbuvir | None of these genes | Unknown |
| Tnf-Alpha | None of these genes | Unknown |
| Udifitimod | None of these genes | Unknown |
| Vancomycin | None of these genes | Unknown |
| Velpatasvir | None of these genes | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.